Shanghai Nianxing Industrial Co., Ltd
China
Product Name: Palmitic acid
Price: Check
Purity: 98.0%
Stocking Period: 10 Day
Contact: Yang
Email: sales@echemcloud.com

2756173-91-6

2756173-91-6 structure

2756173-91-6 structure

Name: CHNQD-01255
Chemical Name: CHNQD-01255
CAS Number: 2756173-91-6
Molecular Formula: C₂₃H₂₉NO₆
Molecular Weight: 415.48
Catalog: Research Areas Cancer
Create Date: 2022-11-21 11:59:39
Modify Date: 2024-04-05 15:01:45
CHNQD-01255 is an orally active Arf-GEFs inhibitor with potent anti-hepatocellular carcinoma (HCC) efficacy[1].

Name	CHNQD-01255

Description	CHNQD-01255 is an orally active Arf-GEFs inhibitor with potent anti-hepatocellular carcinoma (HCC) efficacy[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Others >> Others
In Vitro	CHNQD-01255 (0-1 μM approximately, 72 h) inhibits HepG2 and BEL-7402 cell proliferation[1]. Cell Proliferation AssayCHNQD-01255 (0-1 μM approximately, 72 h) inhibits HepG2 and BEL-7402 cell proliferation[1]. Cell Line: HepG2, BEL-7402 cell Concentration: 0-1 μM approximately Incubation Time: 72 h Result: Inhibited cell proliferation with an IC50 value of 0.1 μM (HepG2) and 0.07 μM (BEL-7402).
In Vivo	CHNQD-01255 (5- 45 mg/kg, p.o.) inhibits tumor growth in HepG2 tumor-bearing xenograft mice[1]. CHNQD-01255 exhibits a high safety profile with MTD values exceeding 750 and 100 mg/kg for p.o. and i.p. administrations in mice[1]. Animal Model: HepG2 tumor-bearing xenograft mice[1] Dosage: 5, 15, and 45 mg/kg Administration: Oral adminstration (p.o.), every day for 21 consecutive days. Result: Resulted in dramatically delayed tumor progression, with a tumor growth inhibition rate (TGI %) value of 61.0% at 45 mg/kg. Animal Model: HepG2 tumor-bearing xenograft mice[1] Dosage: 1 and 9 mg/kg Administration: Intraperitoneal injection (i.p.), every day for 21 consecutive days. Result: Inhibited the tumor growth with the TGI values of 36.6 and 48.3%, respectively. Animal Model: Mice (Pharmacokinetic assay)[1] Dosage: 45 mg/kg p.o., 10 mg/kg i.v. Administration: Oral adminstration (p.o.) or intravenous injection (i.v.) Result: Pharmacokinetic profile of CHNQD-01255. dose (mg/kg) T1/2 (h) Cmax (ng/mL) Cl (mL/h/kg) F (%) 45 (p.o.) 7.35 20.26 598245.37 2.26 10 (i.v.) 2060.78
References	[1]. Yao-Yao Jiang, et al. Design and Characterization of a Natural Arf-GEFs Inhibitor Prodrug CHNQD-01255 with Potent Anti-Hepatocellular Carcinoma Efficacy In Vivo. J Med Chem. 2022 Sep 22;65(18):11970-11984.

Molecular Formula	C₂₃H₂₉NO₆
Molecular Weight	415.48

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.